» Articles » PMID: 38066237

Self-Monitoring and Self-Efficacy in Patients with Chronic Kidney Disease During Low-Sodium Diet Self-Management Interventions: Secondary Analysis of the ESMO and SUBLIME Trials

Overview
Journal Int J Behav Med
Publisher Informa Healthcare
Date 2023 Dec 8
PMID 38066237
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with chronic kidney disease are often requested to engage in self-monitoring sodium (i.e. salt) intake, but it is currently unknown how self-monitoring would empower them. This study aims to assess: (1) how frequent self-monitoring tools are being used during low-sodium diet self-management interventions; (2) whether self-efficacy (i.e. trust in own capability to manage the chronic disease) is associated with self-monitoring frequency; and (3) whether higher self-monitoring frequency is associated with an improvement in self-efficacy over time.

Method: Data from two multicenter randomized controlled trials (ESMO [n = 151] and SUBLIME [n = 99]) among adult Dutch patients with chronic kidney disease (eGFR ≥ 20-25 mL/min/1.73 m) were used. In both studies, routine care was compared to a 3-month low-sodium diet self-management intervention with several self-monitoring tools (online food diary, home blood pressure monitor, and urinary sodium measurement device [only ESMO]). Data was collected on usage frequency of self-monitoring tools. Frequencies during the interventions were compared between low and high baseline self-efficacy groups using the Mann-Whitney U test and T-test and associated with changes in self-efficacy during the interventions using Spearman correlation coefficients.

Results: Large variations in self-monitoring frequency were observed. In both interventions, usage of self-monitoring tools was highest during the first month with sharp drops thereafter. The online food diary was the most frequently used tool. In the ESMO intervention, low baseline self-efficacy was associated with a higher usage frequency of self-monitoring tools. This finding was not confirmed in the SUBLIME intervention. No significant associations were found between usage frequency of self-monitoring tools and changes in self-efficacy over time.

Conclusion: Patients with low self-efficacy might benefit most from frequent usage of self-monitoring tools when sufficient guidance and support is provided.

References
1.
de Borst M, Navis G . Sodium intake, RAAS-blockade and progressive renal disease. Pharmacol Res. 2016; 107:344-351. DOI: 10.1016/j.phrs.2016.03.037. View

2.
Campbell K, Johnson D, Bauer J, Hawley C, Isbel N, Stowasser M . A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol. 2014; 15:57. PMC: 3994521. DOI: 10.1186/1471-2369-15-57. View

3.
McMahon E, Bauer J, Hawley C, Isbel N, Stowasser M, Johnson D . A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013; 24(12):2096-103. PMC: 3839553. DOI: 10.1681/ASN.2013030285. View

4.
de Brito-Ashurst I, Perry L, Sanders T, Thomas J, Dobbie H, Varagunam M . The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart. 2013; 99(17):1256-60. PMC: 3756453. DOI: 10.1136/heartjnl-2013-303688. View

5.
Slagman M, Waanders F, Hemmelder M, Woittiez A, Janssen W, Lambers Heerspink H . Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011; 343:d4366. PMC: 3143706. DOI: 10.1136/bmj.d4366. View